Since hyper-activation of PI3K/Akt signaling has been shown as a shared mechanism responsible for resistance to multiple chemotherapeutic drugs 41, 52-54, we envision that high CapG level may have potential clinical value of predicting poor response to chemotherapy in breast cancer patients. This evidence concerns the gene CAPG and breast carcinoma.